Ying Xian, M.D., Ph.D.
Titles and Appointments
Section Head Research, Stroke & Cerebrovascular Diseases
Associate Professor
- School
- Medical School
- Department
- Neurology
Joined UT Southwestern: 2021
Ying Xian, M.D., Ph.D., FAHA, is a tenured Associate Professor in the Department of Neurology at UT Southwestern Medical Center.
Research: For more than a decade, Dr. Xian’s research has been focused on improving healthcare quality and outcomes in patients with cardiovascular disease and stroke. Before joining the UT Southwestern faculty in 2021, Dr. Xian served as the clinical lead for the AHA/ASA Get With The Guidelines Stroke (GWTG-Stroke) Registry and Society of Thoracic Surgeons (STS) National Database Analytical Center at Duke. He has led multiple groundbreaking comparative effectiveness and patient-centered outcomes research projects, with extensive experience with large national registries and data linkage with Medicare claims.
Dr. Xian has authored or co-authored over 200 peer-reviewed publications and ranks among the World's Top 2% Scientists in clinical medicine by Stanford/Elsevier. He is the Principal Investigator of multiple National Institute on Aging (NIA) funded R01s to evaluate antithrombotic therapy for secondary stroke prevention and post-stroke dementia, and the AHA Clinical Research Program and Scientist Development Grant to investigate off-label/off-guideline thrombolytic therapy in stroke.
Affiliations & Awards: He has been recognized for his research through the AHA QCOR Young Investigator Award and the Northwestern Junior Faculty Clinical Research Award. Dr. Xian has served on multiple committees of the AHA/ASA, including the GWTG Quality Improvement Subcommittee, Stroke Systems of Care Advisory Group, Stroke Council’s Quality and Outcomes Committee, Quality of Care and Outcomes Research (QCOR) Council’s Young Clinicians & Investigators Committee, and GWTG-Stroke Clinical Work Group.
Background: Dr. Xian earned his medical degree at Beijing Medical University (Peking University Health Science Center), completed a residency in Internal Medicine, and a fellowship in Cardiology at Peking University People’s Hospital, and Fuwai Hospital, Peking Union Medical College. Dr. Xian obtained his Ph.D. degree in Health Services Research and Policy at the University of Rochester and received the American Heart Association/American Stroke Association (AHA/ASA) Pharmaceutical Roundtable-Spina Fellowship training in Cardiovascular Outcomes Research at Duke University.
Featured Publications